A late phase II study of LY 188011 (gemcitabine hydrochloride) in patients with non-small-cell lung cancer

Japanese Journal of Cancer and Chemotherapy

Volumn 23, Issue 12, 1996, Pages 1681-1688

  Yokoyama, A ^a   Nakai, Y ^a   Yoneda, S ^a   Kurita, Y ^a   Niitana, H ^a   Taguchi, T ^a  

^a NIIGATA CANCER CENTER HOSPITAL   (Japan)

Author keywords

Gemcitabine; Late phase II study; Non small cell lung cancer

Indexed keywords

GEMCITABINE;

ADULT; AGED; ANOREXIA; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; SEPTIC SHOCK; TREATMENT OUTCOME;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; LEUKOPENIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NAUSEA; NEUTROPENIA; VOMITING;

EID: 0029820128     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)